Renaissance Technologies’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-34,460
| Closed | -$220K | – | 4214 |
|
2023
Q4 | $220K | Buy |
34,460
+8,100
| +31% | +$51.7K | ﹤0.01% | 3104 |
|
2023
Q3 | $113K | Buy |
26,360
+4,500
| +21% | +$19.3K | ﹤0.01% | 3221 |
|
2023
Q2 | $56K | Buy |
21,860
+6,487
| +42% | +$16.6K | ﹤0.01% | 3592 |
|
2023
Q1 | $105K | Buy |
15,373
+2,280
| +17% | +$15.6K | ﹤0.01% | 3482 |
|
2022
Q4 | $93K | Sell |
13,093
-1,174
| -8% | -$8.34K | ﹤0.01% | 3646 |
|
2022
Q3 | $150K | Sell |
14,267
-3,415
| -19% | -$35.9K | ﹤0.01% | 3480 |
|
2022
Q2 | $231K | Sell |
17,682
-12,079
| -41% | -$158K | ﹤0.01% | 3583 |
|
2022
Q1 | $500K | Buy |
29,761
+15,754
| +112% | +$265K | ﹤0.01% | 3196 |
|
2021
Q4 | $416K | Buy |
14,007
+1,040
| +8% | +$30.9K | ﹤0.01% | 3166 |
|
2021
Q3 | $663K | Buy |
+12,967
| New | +$663K | ﹤0.01% | 2768 |
|